When anxiety creeps in at night, sleep often becomes lighter, more fragmented, or simply harder to come by. It is precisely in this context that many adults in France and Europe are turning to hemp-based supplements, particularly CBD, hoping to soothe their minds without seeking a "drowsy" effect.
But what do recent clinical trials actually say? The data is more nuanced than the simplistic marketing promises. The most recent studies suggest interesting signals regarding subjective well-being, certain anxiety profiles, and some specific sleep parameters, without, however, clearly proving a consistent superiority over placebo. Here's what you need to know to sleep better by targeting anxiety.
Why anxiety disrupts sleep so much
Anxiety often acts as a trigger for hypervigilance. At bedtime, instead of slowing down, the mind continues to anticipate, ruminate, review the day, or imagine the next day. As a result, falling asleep takes longer, nighttime awakenings may increase, and the feeling of restorative sleep diminishes.
In this context, the idea behind using a hemp-based supplement isn't necessarily to "force" sleep like a powerful hypnotic. Rather, the goal is to reduce the mental and emotional tension that fuels insomnia, especially in people whose sleep difficulties are closely linked to stress or persistent worries.
This is also reflected in recent clinical literature: the observed benefits often appear to be more psychological than hypnotic. In other words, hemp-based products may help some users feel calmer or sleep better, rather than radically transforming all aspects of sleep for everyone.
Trial 2026: 300 mg of CBD helps more than a low dose, but not clearly more than the placebo
One of the most striking results comes from a 2026 randomized trial conducted with 63 participants described as “high trait worriers,” meaning individuals with a strong tendency toward worry. For two weeks, researchers compared 300 mg/day of CBD, 50 mg/day, and a placebo, paying particular attention to sleep.
The key takeaway is simple: “CBD helps more than a low dose, but not clearly more than a placebo.” In other words, the 300 mg daily dose improved sleep disturbances more than the 50 mg dose, suggesting a possible dose-dependent effect. However, the difference compared to the placebo did not reach statistical significance.
Another important point for those concerned about the following day: no effects on sedation or cognition were observed in this trial. This is reassuring, as many adults are looking for a solution compatible with an active lifestyle, without waking up feeling foggy. While this doesn't confirm a clear effect on sleep, it helps to better define what CBD might, or might not, offer.
2024 trial on insomnia: gains primarily in quality of life
Another landmark clinical trial, published in 2024, evaluated 150 mg of CBD taken at bedtime for two weeks in people with moderate to severe insomnia. The protocol was double-blind, which strengthens the methodological quality of the results.
Researchers observed improved quality of life and better objective sleep efficiency after two weeks. This is interesting because it shows that some effects can be perceived beyond the immediate sensation. However, most other sleep criteria did not differ from the placebo group.
The authors' interpretation is particularly helpful: according to them, CBD taken in the evening seems to produce more pronounced psychological effects than robust hypnotic effects. In practice, this means that a hemp-based supplement might be more beneficial for people whose insomnia is closely linked to stress, inner tension, or difficulty "switching off," rather than as a universal solution for all forms of insomnia.
CBD and terpenes: an interesting avenue for certain profiles
In 2025, a randomized trial explored a formula combining 300 mg of CBD and eight terpenes in 125 people with insomnia over four weeks. This study is interesting because it does not test isolated CBD, but rather an approach closer to certain so-called "formulated" or "full-spectrum" hemp-based supplements, where several plant compounds coexist.
The overall result showed a marginal increase in the proportion of slow-wave sleep + REM sleep of 1.3% on average compared to placebo. Put that way, the figure may seem modest. However, in some subgroups, the gain reached up to 48 minutes per night, which is no longer insignificant for the individuals concerned.
From a safety standpoint, no adverse events were reported. The treatment did not alter total sleep time, resting heart rate, or heart rate variability. This reinforces the idea that some potential benefits may be nuanced, targeted, and dependent on the sleeper's profile, rather than universal. For hemp enthusiasts, this is also a useful reminder: the complete formulation can be just as important as the amount of CBD alone.
What the ongoing trials can still teach us
The research didn't stop there. ClinicalTrials.gov mentions a randomized, double-blind pilot trial evaluating a CBD extract derived from hemp for anxiety, measuring anxiety symptoms and sleep disturbances. Its last published update was on February 3, 2025, confirming that the topic continues to be actively explored.
Another, older but still relevant trial also evaluates a hemp-derived CBD product on anxiety, quality of life, sleep, and cognitive function. The last published update was on August 27, 2024. Here again, we see that the researchers are not only looking at sleep duration, but also at the individual's overall experience.
In addition, an open-label pilot study in 2025 will test a full-spectrum, CBD-rich, hemp-derived sublingual product for six weeks in patients with anxiety, measuring anxiety, mood, sleep, and quality of life. While an open-label study cannot draw the same conclusions as a double-blind trial, it can help identify useful clinical signals and response patterns for further investigation.
The limitations of current evidence: what to avoid overpromising
The major caveat is clear: even recent trials remain small, often short-term, and several conclusions are still cautious. In some cases, the authors cite insufficient evidence to assert a clear effect of CBD on sleep. This is crucial to remember in a field where oversimplification is common.
In practical terms, this means it would be an exaggeration to present hemp-based supplements as a clinically proven solution for everyone to sleep. The results are more nuanced. The most positive signs mainly concern subjective well-being, certain subgroups of insomniacs, and possibly formulas combining CBD and terpenes.
The clear superiority over placebo for sleep remains far from proven. It is precisely this nuance that makes the trials interesting: they do not bury the possibility of hemp, but they force us to discuss doses, profiles, formulation, the context of anxiety, and methodological quality, rather than promising automatic results.
How to interpret these results when looking for a hemp-based supplement
For an adult seeking to improve sleep by targeting anxiety, the most honest reading is this: CBD does not appear to be a powerful sleep aid, but it may be of interest to some users when sleep disturbances are fueled by worry, mental stress, or persistent emotional tension.
Recent trials also suggest that a low dose is not necessarily the most effective. The 2026 study shows that 300 mg/day is more effective than 50 mg/day for sleep disturbances, even if it doesn't clearly outperform the placebo. This suggests that we shouldn't overinterpret the microdoses often promoted, while also remembering that a clinical protocol cannot be directly applied to all products on the market.
Finally, the composition matters. Between isolated CBD, broad-spectrum extract, full-spectrum formulas, and combinations with terpenes, the experience can vary. For discerning consumers, this highlights the value of lab-tested products that comply with legal requirements and are transparent about their composition. In the world of hemp, the actual quality of the product remains at least as important a criterion as the claims made on the packaging.
In summary, recent clinical literature presents a balanced message: hemp-based supplements may be a promising avenue for individuals whose sleep is disrupted by anxiety, but the evidence remains incomplete. The benefits appear to primarily relate to feelings, quality of life, and certain specific profiles, rather than a widespread and uniform demonstration of a hypnotic effect.
The best approach, therefore, is to remain curious, discerning, and realistic. Seeking a well-formulated, legal, and lab-tested hemp product makes sense, but don't expect an instant miracle. When the goal is to improve sleep by targeting anxiety, clinical trials tell us one thing above all: the avenue is promising, but it still requires time, more research, and real attention to the quality of the formulations.
